Be The Match BioTherapies

Be The Match BioTherapies

Be The Match BioTherapies partners with organizations pursuing life-saving cellular therapies in every stage of development – from discovery through commercialization. Built on the foundation established over the last 30 years by the National Marrow Donor Program (NMDP)/Be The Match, we have unparalleled experience managing cellular therapies. Our cell therapy supply chain delivery for autologous or allogeneic therapies is enabled by high-touch, personalized case management and a robust, customizable technology platform, MatchSource®. Our experience in cell sourcing and collection allows us to provide cells consented for research, clinical or commercial use. Researchers have access to clinical trial services through our research program CIBMTR. And, we have the infrastructure in place to collect, store and analyze patient samples post-cell or gene therapy treatment at the time points required by regulatory authorities.

How standardizing audits can help deliver high-quality therapies faster

Overview of the Quality System Audit Program

Q&A with Amy Hines, director of Collection Network Management

The need for a standardized audit approach

How a standardized audit approach can increase efficiencies, reduce costs

Q&A With International Collection Network Manager, Petr Machalik

Reimbursement uncertainties hinder patient access to CAR-T therapies

Be The Match BioTherapies and Cryoport Launch Strategic Partnership

Organization announces collaboration that will deliver end-to-end supply chain services to the cell and gene therapy industry

From then to now: Be The Match BioTherapies builds on decades of cell therapy expertise

Our history begins with the original cell therapy: stem cell transplant

Be The Match BioTherapies Continues Expansion Internationally

Organization announces plans to build an international network to support the cell and gene therapy industry

Cell Lines In-the-News: August 2018